Yi-Hsiung Lin

16PUBLICATIONS
32CO-AUTHORS
Metabolic medicineMolecular targetsCircuits and systemsGene and molecular therapyMedical biotechnology diagnostics (incl. biosensors)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Aug 29, 2025
Atrial arrhythmogenesis and electrophysiological remodeling in hypokalaemic metabolic syndrome: the role of apamin-sensitive SK channels.

Chia-Hao Kuo, Jo-Yun Shih, Yi-Hsiung Lin

|Aug 10, 2024
The Beneficial Effect of the SGLT2 Inhibitor Dapagliflozin in Alleviating Acute Myocardial Infarction-Induced Cardiomyocyte Injury by Increasing the Sirtuin Family SIRT1/SIRT3 and Cascade Signaling.

Yi-Hsiung Lin, Wei-Chung Tsai, Chien-Chih Chiu

|Jan 09, 2024
Up-regulated small-conductance calcium-activated potassium currents contribute to atrial arrhythmogenesis in high-fat feeding mice.

Wei-Chung Tsai, Yi-Hsiung Lin, Chia-Hao Kuo

|Jun 01, 2023
P2Y12 Inhibitor Monotherapy versus Conventional Dual Antiplatelet Therapy in Patients with Acute Coronary Syndrome after Percutaneous Coronary Intervention: A Meta-Analysis.

Wen-Han Feng, Yong-Chieh Chang, Yi-Hsiung Lin

|Apr 13, 2023
Sodium Glucose Cotransporter 2 (SGLT2) Inhibitor Ameliorate Metabolic Disorder and Obesity Induced Cardiomyocyte Injury and Mitochondrial Remodeling.

Shih-Jie Jhuo, Yi-Hsiung Lin, I-Hsin Liu

|May 14, 2022
Comparative Efficacy and Safety of P2Y12 Inhibitor Monotherapy and Dual Antiplatelet Therapy in Patients with and without Diabetes Mellitus Undergoing Percutaneous Coronary Intervention.

Wen-Han Feng, Yong-Chieh Chang, Yi-Hsiung Lin

Pageof 3

Frequent Collaborators

8 joint publications

Wei-Chung Tsai

6 joint publications

Shih-Jie Jhuo

6 joint publications

Bin-Nan Wu

5 joint publications

Hsiang-Chun Lee